Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer’s disease

Written By Yiran Gan

2015.07.23

M. J. Chiu, S. Y. Yang, H. E. Horng, C. C. Yang, T. F. Chen, J. J. Chieh, H. H. Chen, T. C. Chen, C. S. Ho, S. F. Chang, H. C. Liu, C. Y. Hong, H. C. Yang, “Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer’s disease”, ACS Chem. Neurosci. 4(12), ：1530-1536 (2013).

Yiran Gan
Previous

Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease
Next

Development for high-accuracy in-vitro assay of vascular endothelial growth factor using nano-magnetically labeled immunoassay